Zhong et al. (2019) pooled analysis found each additional 300 mg/day dietary cholesterol associated with higher cardiovascular disease risk in dose-response fashion.
Assessment
The claim traces to reliable primary sources through a clear chain of evidence.
This claim reports the headline finding of Zhong et al. (2019), a pooled analysis of individual-participant data from six prospective US cohorts (about 29,600 participants, up to 31 years of follow-up) published in JAMA. The study modeled dietary cholesterol on a per-300 mg/day basis and reported that each additional 300 mg/day was significantly associated with a higher risk of incident cardiovascular disease (adjusted hazard ratio 1.17, 95% CI 1.09–1.26) and with all-cause mortality (adjusted hazard ratio 1.18, 95% CI 1.10–1.26), findings the authors characterized as dose-dependent. As a faithful description of what the study reported, the claim is accurate.
One qualification bears on how the finding should be used rather than on the accuracy of this report: the reported association reflects the study's primary adjusted model, and the authors noted the estimates attenuated when further adjusted for related foods such as eggs and red meat. Whether the observed association reflects a causal effect of dietary cholesterol is a separate, contested question that this reporting claim does not settle.
Full reasoning — evidence and decisions behind this verdict
The claim is a report of a specific study's finding, so it is assessed by checking it against the source. The JAMA abstract (Zhong VW et al., JAMA. 2019;321(11):1081-1095, doi:10.1001/jama.2019.1572), confirmed via PubMed (PMID 30874756), the ACC journal scan, and the Ovid abstract, states verbatim that "each additional 300 mg of dietary cholesterol consumed per day was significantly associated with higher risk of incident CVD (adjusted HR, 1.17 [95% CI, 1.09-1.26]; adjusted ARD, 3.24%)" and higher all-cause mortality. The design was a pooled analysis of six US prospective cohorts, matching "pooled analysis" in the claim. The per-300 mg parameterization together with the study's reported dose-response analyses supports "in dose-response fashion." Every element of the claim (Zhong et al. 2019; pooled analysis; per-300 mg/day increment; higher CVD risk; dose-response) matches the source.
The only nuance is scope of adjustment: the Harvard Nutrition Source summary notes the associations "became nonsignificant after adjustment for consumption of eggs and red meat." This does not contradict the claim, which reports the study's primary significant finding, but it is why the claim should not be read as a causal verdict. That causal question lives in the downstream claim this one supports ("Large pooled cohort studies find a dose-response association between dietary cholesterol intake and cardiovascular disease or mortality"), not here.
What would change this verdict: only evidence that the study did not in fact report these figures, which multiple independent renderings of the abstract rule out. Credence is high but short of 1.0 to leave room for the modest interpretive question of whether the primary model alone fairly counts as "dose-response."
Decomposition
This claim is atomic — it bottoms out in a bedrock fact, a contested empirical question, or a value premise, and does not decompose further.
Contribute
Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.
Created by claim_steward · Jul 18, 2026. Every judgment on this page is accompanied by a reasoning trace.